Polaris Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 32

- Investments
- 834
- Portfolio
- 148
- Exits
- 296

Polaris Partners General Information
Description
Founded in 1996, Polaris Partners is a venture capital firm based in Boston, Massachusetts. The firm prefers to invest in seed, early, later and expansion stage companies operating in the technology and healthcare sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
- One Marina Park Drive
- 10th Floor
- Boston, MA 02210
- United States
+1 (855) 000-0000
Polaris Partners Investments (834)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
The App-Garden Partners | 16-Feb-2021 | Buyout/LBO | Business/Productivity Software | Generating Revenue | 000 0000000 | |
0000000 | 09-Feb-2021 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | |
0000 000000 | 02-Feb-2021 | 00000 00000 | 0000 | Other Healthcare Services | Generating Revenue | |
00000 0000 0000 | 23-Dec-2020 | 0000000000 | Automation/Workflow Software | Generating Revenue | 000 0000000 | |
00000 000000000000 | 16-Dec-2020 | 0000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
0000 (00000 000000 | 15-Dec-2020 | 0000 00000 | 000 | Other Healthcare Technology Systems | Generating Revenue | |
00000000 000 | 11-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
000 | 08-Dec-2020 | 00000 00000 | Legal Services (B2C) | Generating Revenue | 0000 00000000 | |
Primmune Therapeutics | 07-Dec-2020 | Early Stage VC | 000.00 | Drug Discovery | Generating Revenue | 0000 000000 00.0 |
FOLX Health | 03-Dec-2020 | Seed Round | 00.000 | Other Healthcare Services | Generating Revenue |
Polaris Partners Exits (293)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
SQZ Biotech | 12-Feb-2021 | Public Investment 2nd Offering | 0000 |
000000 | 02-Feb-2021 | 000000000000000000 | 00.00 |
000 0000000 | 30-Oct-2020 | 000 | 000.00 |
000000 000 | 09-Oct-2020 | 000 | 00000 |
000000000 | 16-Sep-2020 | 000 | 0000 |
000000000 | 07-Sep-2020 | 000000000000000000 | 00.000 |
0000000 0000000 | 18-Aug-2020 | 000000000000000000 | |
0000000 | 12-Aug-2020 | 0000000000 | |
Pandion Therapeutics | 17-Jul-2020 | IPO | 00000 |
Lyra Therapeutics | 01-May-2020 | IPO | 0000 |
Polaris Partners Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Polaris Partners‘s full profile, request access.
Request a free trialPolaris Partners Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialPolaris Partners Team (102)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Harold Friedman | Chief Financial Officer | San Francisco, CA | |||
Bryce Youngren | Managing Partner | 00 | 0 | 0 | Boston, MA |
Terrance McGuire | Co-Founding Partner | 00 | 0 | 00 | Boston, MA |
Brendan Hannigan | Entrepreneur Partner | 0 | 0 | 0 | Boston, MA |
Jim Weinstein | Entrepreneur Partner | Boston, MA |
Polaris Partners Co-Investors (381)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
ARCH Venture Partners | 10 | 0 |
![]() |
![]() |
|
GV | 0 | 0 | 0 |
![]() |
![]() |
Alexandria Venture Investments | 0 | 0 | 0 |
![]() |
![]() |
The Invus Group | 0 | 0 |
![]() |
![]() |
|
EcoR1 Capital | 0 | 0 |
![]() |
![]() |